Skip to main content
Caplight Logo









Partillion Bioscience Corporation

Partillion Bioscience Corporation

Private
Los Angeles, CaliforniaHealthcare & Life Scienceshttps://www.partillion.com/

Last Round

Seed

Sep 26, 2023

Total Funding Raised

$8.25M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Partillion Bioscience Corporation is a biotechnology company that provides a nanovial platform for the rapid compartmentalization and analysis of millions of single cells to probe biological functions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Infrastructure

Keywords

single-cell analysisnanovial technologyhigh-throughput screeningflow cytometryfunctional single-cell screeningsingle-cell sequencingbiological foundation modelsdrug discovery toolsassay kitssingle-cell proteomicslab-on-a-chipbiotech consumablesai-ready biology datamicrofluidics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Partillion Bioscience Corporation Comparables

Compare Partillion Bioscience Corporation with similar companies based on industry and business-model similarity.

Partillion Bioscience Corporation comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CellChorus
81%
LiveDrop SA
80%
Sampling Human, Inc.
79%

Partillion Bioscience Corporation Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 26, 2023
GrantSep 13, 2023
GrantSep 6, 2023
GrantSep 1, 2021

Key People

Founding team and executive leadership

Joe de Rutte

Co-Founder and CEO

Founding Team

Partillion Bioscience Corporation Investors

Notable investors and investment history

Partillion Bioscience Corporation investors
InvestorRounds
NIH RADxGrant
Vertical Venture PartnersSeed
ND CapitalSeed
General InceptionSeed
National Science FoundationGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Monthly visitors increased 31% MoM.

  • Apr 21, 2026

    Attended the 2026 Cell-Cell Symposium and introduced new progress in cell interaction studies.

Partillion Bioscience Corporation Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Partillion Bioscience Corporation Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Partillion Bioscience Corporation's valuation, stock price, and market status.

Firmographic Details

HeadquartersLos Angeles, California
Employee Range15
Year Founded2020
Last FundingSep 26, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?